Skip to main content

Advertisement

Table 3 Spending on R&Da and promotion as a percent of sales for companies with the most heavily promoted drugs

From: Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis

Year Number of companiesb Number of drugs Total sales ($000) R&D spending ($000) (% sales) Promotion spending ($000) (% sales) Ratio of R&D to promotion spending Number of companies spending more on promotion than on R&D
2013 22 46 12,761,798 565,670 (4.4) 243,420 (1.9) 2.32 9
2014 22 46 13,327,819 509,531 (3.8) 242,401 (1.8) 2.11 8
2015 22 45 13,215,385 487,223 (3.7) 230,157 (1.7) 2.18 9
2016 22 49 13,610,805 553,057 (4.1) 258,363 (1.9) 2.16 10
  1. aResearch and development
  2. bIndividual companies vary by year